immune response to tirzepatide for diabetes: on track SURPASS current therapy Shifting the Scales: Tirzepatide's Breakthrough

Faced with the threat of chronic conditions from weight gain, Thomas connected with a provider who helped him find more beneficial exercise methods for his life off the field

Tirzepatide is administered via a small subcutaneous injection once per week

The lower Mounjaro doses map step for step onto the Wegovy titration ladder

Nat Rev Endocrinol 8:728742 Gough SC, Bode B, Woo V et al (2014) Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

Note that all prescriptions are at the discretion of your health care provider

Lose 54% more weight with Weight Watchers* With Med+, you get more than a prescriptionyou get a whole weight-loss plan